Radiant Innovation

Radiant Innovation ROCE

The Return on Capital Employed (ROCE) of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is -8.86 %. In the previous year, Return on Capital Employed (ROCE) was -6.80 % — a change of 30.33% (lower).

ROCE

-8.86 %

YoY

30.33%

Last updated:

In 2025, Radiant Innovation's return on capital employed (ROCE) was -8.86 %, a 30.33% increase from the -6.80 % ROCE in the previous year.

The Radiant Innovation ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
1.57 TWD
Jan 1, 2019
4.59 TWD
Jan 1, 2020
70.63 TWD
Jan 1, 2021
14.00 TWD
Jan 1, 2022
-1.49 TWD
Jan 1, 2023
-8.23 TWD
Jan 1, 2024
-6.80 TWD
Jan 1, 2025
-8.86 TWD
The Radiant Innovation ROCE history
YEARROCEYoY
-8.86 %+30.33%
-6.80 %-17.32%
-8.23 %+453.60%
-1.49 %-110.62%
14.00 %-80.18%
70.63 %+1,437.81%
4.59 %+191.78%
1.57 %-67.86%
4.90 %-34.59%
7.49 %-14.20%
8.73 %+114.14%
4.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Radiant Innovation's Return on Capital Employed (ROCE)

Radiant Innovation's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Radiant Innovation's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Radiant Innovation's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Radiant Innovation’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Radiant Innovation stock

Return on Capital Employed (ROCE) of Radiant Innovation is -8.86 % in 2025.

Return on Capital Employed (ROCE) of Radiant Innovation changed from -6.80 % to -8.86 %, representing a 30.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Radiant Innovation with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Radiant Innovation

All Key Metrics — Radiant Innovation